GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Encompass Health Corp (NYSE:EHC) » Definitions » Altman Z2-Score

EHC (Encompass Health) Altman Z2-Score : 1.83 (As of Nov. 30, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Encompass Health Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Encompass Health has a Altman Z2-Score of 1.83, indicating it is in Grey Zones. This implies that Encompass Health is in some kind of financial stress. If it is below 1.1, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Encompass Health's Altman Z2-Score or its related term are showing as below:

EHC' s Altman Z2-Score Range Over the Past 10 Years
Min: -0.01   Med: 1.26   Max: 1.91
Current: 1.83

During the past 13 years, Encompass Health's highest Altman Z2-Score was 1.91. The lowest was -0.01. And the median was 1.26.


Encompass Health Altman Z2-Score Historical Data

The historical data trend for Encompass Health's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Encompass Health Altman Z2-Score Chart

Encompass Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 1.05 1.42 1.34 1.70

Encompass Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.64 1.70 1.85 1.91 1.83

Competitive Comparison of Encompass Health's Altman Z2-Score

For the Medical Care Facilities subindustry, Encompass Health's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Encompass Health's Altman Z2-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Encompass Health's Altman Z2-Score falls into.



Encompass Health Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Encompass Health's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.0057+3.26*0.1073+6.72*0.132+1.05*0.525
=1.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Sep. 2024:
Total Assets was $6,458 Mil.
Total Current Assets was $934 Mil.
Total Current Liabilities was $897 Mil.
Retained Earnings was $693 Mil.
Pre-Tax Income was 183.8 + 186 + 178.4 + 164.8 = $713 Mil.
Interest Expense was -34.9 + -34.3 + -35.2 + -34.9 = $-139 Mil.
Total Liabilities was $3,733 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(933.9 - 897.4)/6458.4
=0.0057

X2=Retained Earnings/Total Assets
=693.2/6458.4
=0.1073

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(713 - -139.3)/6458.4
=0.132

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(1959.8 - 0)/3732.8
=0.525

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Encompass Health has a Altman Z2-Score of 1.83 indicating it is in Grey Zones.


Encompass Health  (NYSE:EHC) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Encompass Health Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of Encompass Health's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Encompass Health Business Description

Traded in Other Exchanges
Address
9001 Liberty Parkway, Birmingham, AL, USA, 35242
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Executives
Douglas E Coltharp officer: EVP, Chief Financial Officer C/O UNDER ARMOUR, INC., 1020 HULL STREET, BALTIMORE MD 21230
Elissa Joy Charbonneau officer: Chief Medical Officer 24 HAWTHORNE CIRCLE, YARMOUTH ME 04096
John Patrick Darby officer: EVP, Gen Counsel & Secretary 3115 OVERHILL ROAD, BIRMINGHAM AL 35223
Greg D Carmichael director
Mark J Tarr officer: Executive VP Operations C/O ENCOMPASS HEALTH CORPORATION, 9001 LIBERTY PARKWAY, BIRMINGHAM AL 35242
Kevin J. O'connor director 13995 PASTEUR BOULEVARD, PALM BEACH GARDENS FL 33418
Terrance Williams director 7184 BIDDICK, NEW ALBANY OH 43054
Christopher R Reidy director ONE ADP BLVD, ROSELAND NJ 07068
Andrew L Price officer: Interim Chief Accting Officer 3660 GRANDVIEW PARKWAY, SUITE 200, BIRMINGHAM AL 35243
Barbara Ann Jacobsmeyer officer: EVP, Operations 2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Donald L Correll director C/O INTERCHANGE FINANCIAL SERVICES CORP, PARK 80 W PLAZA TWO, SADDLE BROOK NJ 07663
Anthony April Kaye Bullock officer: CEO and President, Encompass 3606 PRINCETON AVENUE, DALLAS TX 75205
Higdon Leo I Jr director 1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Patricia Anne Maryland director 7342 HORIZON DRIVE, WEST PALM BEACH FL 33412
Yvonne M Curl director C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206